Singapore markets closed

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.41+0.73 (+8.41%)
At close: 04:00PM EDT
9.37 -0.04 (-0.43%)
Pre-market: 04:41AM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-449,643
-444,037
-395,893
-342,252
-259,581
-
Depreciation & amortisation
37,337
33,127
21,135
13,980
8,712
-
Deferred income taxes
-4,887
-3,479
0
0
-
-
Stock-based compensation
64,138
62,625
84,022
69,765
40,887
-
Change in working capital
-26,241
-6,521
-2,892
24,553
2,983
-
Accounts receivable
-232
-149
0
0
-
-
Inventory
-16,853
-10,118
0
0
-
-
Accounts payable
-4,012
4,828
5,883
6,976
-2,964
-
Other working capital
-405,081
-384,110
-313,182
-265,515
-251,925
-
Other non-cash items
-
-
-
-
7,572
-336
Net cash provided by operating activities
-384,284
-361,820
-292,757
-227,941
-205,134
-
Cash flows from investing activities
Investments in property, plant and equipment
-20,797
-22,290
-20,425
-37,574
-46,791
-
Acquisitions, net
-265,206
-212,633
0
0
-
-
Purchases of investments
-342,341
-205,902
-245,816
-725,208
-947,663
-
Sales/maturities of investments
208,200
285,583
522,696
762,914
676,601
-
Net cash used for investing activities
-420,144
-155,242
256,455
132
-317,853
-
Cash flows from financing activities
Common stock issued
401,093
463,281
189,502
203,156
567,043
-
Other financing activities
-5,567
-2,795
-2,649
-
-284
-312
Net cash used provided by (used for) financing activities
398,363
462,959
190,150
239,268
576,422
-
Net change in cash
-409,296
-56,843
153,848
11,459
53,435
-
Cash at beginning of period
549,914
238,161
84,313
72,854
19,419
-
Cash at end of period
143,849
181,318
238,161
84,313
72,854
-
Free cash flow
Operating cash flow
-384,284
-361,820
-292,757
-227,941
-205,134
-
Capital expenditure
-20,797
-22,290
-20,425
-37,574
-46,791
-
Free cash flow
-405,081
-384,110
-313,182
-265,515
-251,925
-